[{"address1": "10224 Falls Road", "city": "Potomac", "state": "MD", "zip": "20854", "country": "United States", "phone": "301 983 0998", "website": "https://igcpharma.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.", "fullTimeEmployees": 67, "companyOfficers": [{"maxAge": 1, "name": "Mr. Ram  Mukunda", "age": 64, "title": "President, CEO & Director", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 755000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Claudia  Grimaldi", "age": 51, "title": "VP, Principal Financial Officer, Chief Compliance Officer & Non-Independent Director", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 347000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Rohit  Goel", "age": 29, "title": "Senior Director of Accounting & Principal Accounting Officer", "yearBorn": 1994, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "maxAge": 86400, "priceHint": 4, "previousClose": 0.4358, "open": 0.423, "dayLow": 0.423, "dayHigh": 0.4701, "regularMarketPreviousClose": 0.4358, "regularMarketOpen": 0.423, "regularMarketDayLow": 0.423, "regularMarketDayHigh": 0.4701, "beta": 1.304, "forwardPE": -2.775625, "volume": 189463, "regularMarketVolume": 189463, "averageVolume": 502690, "averageVolume10days": 124700, "averageDailyVolume10Day": 124700, "bid": 0.44, "ask": 0.4441, "bidSize": 1100, "askSize": 800, "marketCap": 33590124, "fiftyTwoWeekLow": 0.25, "fiftyTwoWeekHigh": 0.91, "priceToSalesTrailing12Months": 24.97407, "fiftyDayAverage": 0.4754, "twoHundredDayAverage": 0.37555, "currency": "USD", "enterpriseValue": 32737134, "floatShares": 68619628, "sharesOutstanding": 75636400, "sharesShort": 1238106, "sharesShortPriorMonth": 1372078, "sharesShortPreviousMonthDate": 1717113600, "dateShortInterest": 1719532800, "sharesPercentSharesOut": 0.0164, "heldPercentInsiders": 0.081829995, "heldPercentInstitutions": 0.21393, "shortRatio": 5.62, "shortPercentOfFloat": 0.0166, "bookValue": 0.11, "priceToBook": 4.0372725, "lastFiscalYearEnd": 1711843200, "nextFiscalYearEnd": 1743379200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -13000000, "trailingEps": -0.22, "forwardEps": -0.16, "lastSplitFactor": "1:10", "lastSplitDate": 1366329600, "enterpriseToRevenue": 24.34, "enterpriseToEbitda": -3.574, "exchange": "ASE", "quoteType": "EQUITY", "symbol": "IGC", "underlyingSymbol": "IGC", "shortName": "IGC Pharma, Inc.", "longName": "IGC Pharma, Inc.", "firstTradeDateEpochUtc": 1148477400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "dce893e5-9c03-3b1b-b9a2-7af606299cd2", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.4441, "targetHighPrice": 3.25, "targetLowPrice": 3.25, "targetMeanPrice": 3.25, "targetMedianPrice": 3.25, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 1198000, "totalCashPerShare": 0.016, "ebitda": -9161000, "totalDebt": 345000, "quickRatio": 0.551, "currentRatio": 1.583, "totalRevenue": 1345000, "debtToEquity": 4.712, "revenuePerShare": 0.023, "returnOnAssets": -0.45227, "returnOnEquity": -1.16949, "freeCashflow": -3168750, "operatingCashflow": -5199000, "revenueGrowth": 0.777, "grossMargins": 0.54498, "operatingMargins": -9.884749, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-07-14"}]